William A. Haseltine PhD is chairman of Haseltine Global Health LLC, a virtual pharmaceutical company dedicated to developing new and more efficient means to develop new life-saving drugs and medical devices. He is also president of the Haseltine Foundation for Medical Sciences and the Arts, a foundation that supports access to high-quality health for the poor and middle class of developing countries and that also fosters a dialog between sciences and the arts. He is an adjunct professor at the Scripps Institute for Medical Research.
William has an active career in both science and business. He was a professor at Harvard Medical School from 1976 to 1993, where he was the chair of two academic research departments. He is well-known for his pioneering work on cancer and HIV/AIDS. He is the founder of Human Genome Sciences Inc and served as the chairman and CEO of the company until 2004. He is also the founder of seven other successful biotechnology companies. He serves as an advisor to CMEA, a venture capital company, and to several biotechnology and pharmaceutical companies.
William is active in public service. He is co-chair of the President's Council of the Cold Spring Harbor Laboratory, a member of the advisory board of the Global Coalition on HIV/AIDS, a member of the board of One World Health, a member of the CEO Council of the New York Academy of Science, and chair of the Berkeley Center of Synthetic Biology. He is a member of the executive committee of the Brookings Institution, a member of both the Council on Foreign Relations and the Trilateral Commission, and a member of the Chairman's Circle of the Asia Society.
He resides in Washington, D.C. and New York City.